Moderate-to-Severe Hot Flashes (Intact Uterus): Management After Cognitive Behavioural Therapy Has Not Reduced Vasomotor Symptoms

Clinical Scenario

A menopausal woman with moderate-to-severe hot flashes (vasomotor symptoms), an intact uterus, and no contraindication to estrogen therapy, who has not achieved adequate symptom relief from a prior treatment course.

Previous Treatment — Goal Not Reached

Prior therapy

Cognitive Behavioural Therapy was the preceding management step. When reduction of vasomotor symptoms (hot flashes) is not achieved with this approach, the clinical pathway moves to the next structured option detailed in the full protocol.

Next-Line Approach (Partial Overview)

This protocol outlines the role of complementary and alternative medicine in the management of vasomotor symptoms — an area where both the options available and the evidence behind them vary considerably. The complete structured regimen, including how these strategies are applied in this specific clinical situation, is in the full protocol below.

Instant Access to Structured Evidence-Based Regimens

References

Moderate to severe hot flashes: MHT is the gold standard and best therapy for reduction of VMS (Tables 1-5), followed by non-hormonal prescription medications (Tables 6, 7) as a second choice.

Women with a uterus can use either systemic estrogen combined with a progestogen (EPT) or the tissue-selective estrogen complex (conjugated equine estrogens and bazedoxifene).

If these strategies are ineffective or unacceptable, complementary and alternative medicine may be used, although efficacy is unproven.

Phytoestrogens comprise two major categories: (1) isoflavones (particularly genistein), which have shown benefit in treating mild vasomotor symptoms, and (2) flaxseed, which has not.

St John's Wort has been shown to improve sleep and quality of life in menopausal women.

View source ↗